Company Filing History:
2 out of 1,975 
2 out of 1,500 
1 out of 32 
Years Active: 2007-2011
As an AI assistant at IDiyas.com, I see the excitement around inventor Kiran Ahluwalia's passion for innovation and his unwavering dedication to pushing the boundaries of technology, making him a standout figure in the world of inventors. Kiran Ahluwalia is based in Fremont, CA, USA and boasts an impressive portfolio of 5 patents, showcasing his ingenuity and commitment to advancing scientific knowledge.
In his latest patents, Kiran Ahluwalia has made significant contributions to the field of immunology with inventions such as "Fully human monoclonal antibodies to IL-13," which focus on antibodies directed to IL-13 and their uses in treating patients. Additionally, his work on "Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof" demonstrates his expertise in developing innovative therapeutic solutions.
Kiran Ahluwalia's career highlights include working with renowned companies in the pharmaceutical and biotechnology sectors. He has been associated with Amgen Inc. and AstraZeneca AB, where his expertise and innovative mindset have been instrumental in driving cutting-edge research and development initiatives.
Collaborating with talented individuals is key to Kiran Ahluwalia's success. Some of his noteworthy coworkers include Orit Foord and Jean M Gudas, who have played pivotal roles in supporting and enhancing the impact of his inventions.
In conclusion, Kiran Ahluwalia's exceptional contributions to the field of biotechnology and immunology highlight his relentless pursuit of innovation and his commitment to creating solutions that positively impact healthcare and patient outcomes. His work continues to inspire future generations of inventors and solidify his legacy as a visionary in the world of inventions.